A lump may be small. A change in the skin may seem easy to dismiss. Discharge or redness may be attributed to something temporary. But when a change in the breast is unusual or persistent, doctors say it should not be ignored. In Jammu and Kashmir, clinicians are concerned not only about the number of women developing breast cancer, but also about how late some reach a hospital for diagnosis.
Breast cancer is the most common cancer among women in the Union Territory, according to the figures cited in the original reporting. It accounts for about 19 per cent of cancers among women, with stomach cancer a distant second at around 9 per cent. The figures underline the importance of awareness, timely assessment and access to diagnostic services.
At the beginning of 2026, the J&K government told the legislature that 32,425 cancer cases had been reported in the Union Territory over three years. Lung, breast, oral, cervical, prostate and pancreatic cancers were among the common forms. In the Kashmir division, reported cases rose from 8,021 in 2022 to 8,621 in 2023 and 8,979 in 2024.
Those totals cover different cancers and should not be confused with breast-cancer incidence alone. They do, however, provide a broader picture of the burden facing health services. Figures placed before the Rajya Sabha projected 938 new breast cancer cases in J&K for 2025. Such estimates and hospital-reported totals are not directly interchangeable: they may use different methods, years and population assumptions. The distinction is important when assessing the scale of disease.
A narrative review published in January 2026 in the journal Cureus examined the epidemiological landscape of breast cancer in Jammu and Kashmir. It described a pattern of late-stage presentation and discussed the distribution of molecular subtypes, awareness and psychosocial factors. The review also cited an increase of about 39 per cent in breast cancer incidence between 1990 and 2016. As a review of existing studies, it synthesised available research rather than presenting a new population-wide screening survey.
Doctors say the age profile is also a concern. Dr Shaqul-Qamar Wani, Additional Professor in Radiation Oncology at the State Cancer Institute, said at a breast cancer screening event at SKIMS Soura that clinicians were seeing women in their thirties and, in some cases, their twenties. The observation does not mean that breast cancer is common among all young women, but it challenges the assumption that the disease is relevant only after middle age.
Dr Aiffa Aiman, Additional Professor in the Department of Pathology at SKIMS Soura, has stressed the importance of pathological evaluation when a woman notices a lump. She said new testing methods were available and advised women with an unusual change — including a lump, discharge or redness — to seek medical assessment, radiological examination and, where needed, pathological evaluation.
The sequence matters. Not every lump is cancer, and a self-examination cannot establish a diagnosis. Its value is in helping a woman become familiar with what is normal for her and notice a change that warrants professional assessment. A clinician can determine what examination is appropriate. Imaging and pathology may be needed to establish whether a suspicious change is malignant and, if it is, what kind of cancer is present.
Dr Shahida Nasreen, Additional Professor in Radiation Oncology at SKIMS Soura, has said that many women do not consult a doctor even after noticing a concerning change. She urged them not to shy away from seeking help and pointed out that female doctors are available in Kashmir. Her appeal speaks to a barrier that is not solved by diagnostic equipment alone. Fear, embarrassment, lack of awareness and anxiety about the consequences of a diagnosis can all delay a visit.
The consequences of delay can be serious. Cancer detected at an advanced stage may require more complex treatment and can be harder to manage. The Cureus review found that late-stage presentation was a recurring feature in the literature it examined. It also discussed aggressive subtypes, including triple-negative breast cancer, as part of the regional research picture. These findings should be interpreted in the context of the studies reviewed, not as proof that every patient in J&K has an aggressive form of the disease.
The challenge is to make early assessment accessible and understandable. Awareness campaigns can explain warning signs, but they must also tell women where to go and what to expect. Primary health facilities need clear referral pathways. Diagnostic services must be available without unnecessary delays, and women should be able to obtain counselling that respects privacy and dignity.
Screening and diagnosis are related but distinct. Screening looks for disease in people who may not have symptoms, while diagnostic assessment investigates a symptom or abnormal finding. A woman who notices a new lump should not wait for a general screening camp before seeking medical advice. Conversely, the availability and appropriateness of population screening depend on age, risk, resources and public-health guidance. Advice should come from qualified clinicians rather than broad claims circulated online.
The figures also point to a need for better cancer data. Population-based registries can help show how many people are diagnosed, at what ages, in which areas and with what outcomes. Hospital totals are useful, but they may not capture every case in the population. Estimates, reported cases and registry data should be presented with their methods clearly stated so that policymakers and the public can compare like with like.
For women, the first step is often the most difficult: deciding that a change deserves attention and making an appointment. Doctors say that a lump, unusual discharge, redness or another persistent change should be evaluated rather than hidden or watched indefinitely. Early consultation does not guarantee a particular outcome, but it allows clinicians to investigate before a disease has progressed further.
Breast cancer is not a private failing, and a diagnosis is not a reason for shame. The responsibility lies with health systems to provide accessible evaluation and treatment, and with public communication to make seeking help less intimidating. The warning from doctors is simple: notice a change, consult a qualified professional and do not let fear turn an early sign into a late diagnosis.
About the Author
Syed Sameer Ahmad Nazki is a filmmaker skilled in editing and videography, with an interest in visual storytelling and sports.
